Under this scenario, loss of SHH expression due to hypermethylation leads to the decreased expression of stromal BMP, which in turn stimulates the formation of the basal subtype of human bladder cancer, with poor clinical outcomes. The gene discussed is SHH; the disease is urinary bladder cancer.